ReviewMolecular cancer2025
Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors.
Jiyuan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it